All Thomas Jefferson University articles
-
NewsNIH-sponsored trial of Lassa vaccine opens
A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.
-
NewsInitiative to start HPV vaccination at age 9 improved completion rates
A quality improvement program designed to increase earlier uptake of the human papillomavirus (HPV) vaccine raised vaccination rates significantly, according to a study.
-
NewsResearchers develop promising Lassa fever vaccine
Researchers have developed a promising new vaccine candidate that protects against Lassa fever. The vaccine effectively prevents severe cases of the disease and death in preclinical animal models and paves the way for research in people.
-
NewsStudy explores microbiome of hip and knee osteoarthritis
Next-generation DNA sequencing (NGS) techniques show the presence of bacterial DNA in surgical specimens of hip and knee arthritis, from patients undergoing first-time total joint arthroplasty, a new study reports.